Tag: Bharat Biotech

Cap Covid-19 medicines, vax prices, issue compulsory license to scale up output: RSS-affiliate SJM to govt

Rashtriya Swayamsevak Sangh-affiliate Swadeshi Jagran Manch (SJM) has urged the Centre to provide regulatory clearance for the local production of the Russian Sputnik V vaccine,...

Apply the law to accelerate Covaxin output: Legal experts say sufficient legal provisions to ask several private companies to make the vaccine

Of the many ways India can ramp up vaccine production, widely sharing output responsibilities of Covaxin can be one of the most effective. Legal experts...

View: Express vaccination is our saviour

India is reeling under the second wave of the pandemic. On April 25, 2021, we reported over 3.5 lakh cases of fresh infections from the...

Civil society petition in SC for compulsory licence for vaccine, key Covid drugs

Civil society organisation Jan Swasthya Abhiyan (Mumbai) has filed a petition in the Supreme Court seeking direction to the Centre to issue compulsory licenses for...

india covid vaccination: Mass vaccination, India’s COVID-19 escape route, poses a giant challenge

India is the world’s leading producer of vaccines, but over the past week it has also been the global leader in COVID-19 deaths, and it...

South awaits vaccine supply timelines to fix launch dates

Five major southern states will be able to kick off the vaccination campaign for people in the 18-44 year age group only after a week...

Inoculation 3.0: South waiting for supply timeline from vaccine makers before committing to launch date

Five major southern states will be able to kick-off the vaccination campaign for people in the 18-44 year age group only after a week or...

US should grant India special waiver from DPA for vaccine raw materials

The United States ought to consider granting India a special exemption or waiver from the imposition of its Defence Production Act (DPA) on raw materials...

Vaccination drive for all above 18 years may get delayed as states yet to get a clarity on delivery

Registration for vaccinations for all above the age of 18 may have started on Wednesday but there seems to be a slip between the cup...

Covid-19: States unsure of vaccination Phase 3 | India News

NEW DELHI: It’s just two more days to India’s third phase of vaccination to begin – which will see those between 18 and 45 years...

Congress accuses government of facilitating vaccine profiteering | India News

NEW DELHI: Congress on Sunday accused the Modi government of facilitating vaccine profiteering amid the steep and persistent rise in coronavirus cases in the country....

covaxin: Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum

To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, Covaxin, to 700...

India to have 5 more COVID vaccines by Oct, Sputnik may get emergency use nod in 10 days

As more and more states flag shortage of COVID-19 vaccine doses, the Central government has pressed the accelerator to scale up vaccine production manifold. Top...

India planning to double Covid vaccine output to 140 million by August

India may more than double local production of Covid-19 vaccines to 140 million doses a month by August, according to a presentation to the Prime...

Chhattisgarh, Punjab, Kerala shed Covaxin hesitancy

The opposition-ruled states of Chhattisgarh, Punjab and Kerala have finally given up Covaxin “hesitancy” and are deploying the vaccine in Covid-19 public immunisation drive. Congress-ruled...

Covaxin out of clinical trial mode, granted restricted emergency use authorisation | India News

NEW DELHI: The Centre on Thursday said Bharat Biotech‘s indigenously developed Covaxin is out of the “clinical trial mode” and that it has now been...

India’s massive vaccine campaign boosted by PM Modi receiving shot | India News

Following a sluggish start, India’s Covid-19 vaccination drive — one of the world’s biggest — has jumped nearly four-fold after the country opened it up...

Covid-19: Interim clinical efficacy of Covaxin is 81%, says Bharat Biotech | India News

HYDERABAD: India’s first indigenous Covid-19 vaccine Covaxin has demonstrated an 81% efficacy in preventing Covid-19 after the second dose, as per the interim results of...

Covid vax price to be capped at R250/dose at private hospitals | India News

PUNE/NEW DELHI: Private hospitals can charge up to Rs 250 for a dose of Covid vaccine, including the hospital’s user fee of around Rs 100,...

Centre set to charge for vaccines at private hospitals

As India expands its public immunisation drive to senior citizens above 60 years and persons above 45 years with comorbidities, it would charge for the...

No data on efficacy of India’s Covid vaccines against South African, Brazilian variants: Scientists | India News

NEW DELHI: Preliminary research shows the two vaccines against Covid-19 approved in India are effective against the UK variant of the novel coronavirus but there...

As vaccination drive picks up, Govt eyes to give shots to 50-plus group | India News

NEW DELHI: The vaccination drive against Covid-19 is set to be ramped up, targeting a larger population group of around 26 crore people above 50...

Lack of clarity on Covid vaccines’ safety may derail India’s next phase of inoculation

New Delhi: Nearly a month after India started its vaccination drive, there is still no clarity if the vaccines can be administered to immunocompromised people...

Bharat Biotech: Controversy swirls around India’s homegrown Covid-19 vaccine

A year ago, Krishna Ella was simply known for running a small Indian pharmaceutical company with a reputation for scientific rigor. Then came the pandemic...

Covaxin effectively neutralises UK variants: Bharat Biotech | India News

HYDERABAD: India’s first indigenous Covid-19 vaccine Covaxin effectively neutralises the deadly and infectious UK variants of SARS-CoV-2 virus, reducing the possibility of mutant virus escape,...